D-psicose inhibits intestinal α-glucosidase and suppresses the glycemic response after ingestion of carbohydrates in rats

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 2, 2009, Pages 202-206

  Matsuo, Tatsuhiro ^a   Izumori, Ken ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

D psicose; Maltase; Plasma glucose; Rat; Sucrase

Indexed keywords

ALPHA GLUCOSIDASE; AMYLASE; FRUCTOSE; GLUCOSE; MALTOSE; PSICOSE; SOLUBLE STARCH; STARCH; SUCRASE; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDICINAL PLANT; NONHUMAN; POSTPRANDIAL STATE; RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 70350337544     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-36     Document Type: Article

References (35)

1. Green, G.M. and Perlin, A.S.: O-Isopropylidene derivatives of D-allulose (D-psicose) and D-erythro-hexopyranose-2,3-diulose. Can. J. Biochem., 46, 765-770, 1968.
2. Granstrom, T.B., Takata, G., Tokuda, M., and Izumori, K.: Izumoring: a novel and complete strategy for bioproduction of rare sugars. J. Biosci. Bioeng., 97, 89-94, 2004.
3. Matsuo, T., Suzuki, H., Hashiguchi, M., and Izumori, K.: D-Psicose is a rare sugar that provides no energy to growing rats. J. Nutr. Sci. Vitaminol., 48, 77-80, 2002.
4. Matsuo, T., Baba, Y., Hashiguchi, M., Takeshita, K., Izumori, K, and Suzuki, H.: Dietary D-psicose, a C-3 epimer of D-fructose, suppresses the activity of hepatic lipogenic enzymes in rats. Asia Pacific J. Clin. Nutr., 10, 233-237, 2001.
5. Matsuo, T., Baba, Y., Hashiguchi, M., Takeshita, K., Izumori, K., and Suzuki, H.: Less body fat accumulation with D-psicose diet versus D-fructose diet. J. Clin. Biochem. Nutr., 30, 55-65, 2001.
6. Matsuo, T., Tanaka, T., Hashiguchi, M., Izumori, K., and Suzuki, H.: Effects of oral acute administration and subchronic feeding of several levels of D-psicose in rats. J. Nutr. Sci. Vitaminol., 48, 512-516, 2002.
7. Matsuo, T., Tanaka, T., Hashiguchi, M., Izumori, K., and Suzuki, H.: Metabolic effects of D-psicose in rats: studies on faecal and urinary excretion and caecal fermentation. Asia Pacific J. Clin. Nutr., 12, 225-231, 2003.
8. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent-diabetes mellitus. N. Engl. J. Med., 329, 977-986, 1993.
9. Toeller, M.: Nutritional recommendations for diabetic patients and treatment with α-glucosidase inhibitors. Drugs, 44 Suppl. 3, 13-20, 1992.
10. Lebovitz, H.E.: Oral antidiabetic agents: The emergence of a-glucosidase inhibitors. Drugs, 44 Suppl. 3, 21-28, 1992.
11. Puls, W., Keup, U., and Krause, H.P.: Glucosidase inhibition: A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften, 64, 536-537, 1977. (Pubitemid 8197894)
12. Caspary, W.F. and Graf, S.: Inhibition of human intestinal α-glucosidase hydrolases by a new complex oligosaccharide. Res. Exp. Med., 175, 1-6, 1979.
13. Puls, W., Keup, U., and Krause, H.P.: Pharmacology of α-glucosidase inhibitor. Front Horm. Res., 7, 235-247, 1980.
14. Seri, K., Sanai, K., Matsuo, N., Kawakubo, K., Xue, C., and Inoue, S.: L-Arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism, 45, 1368-1374, 1996. (Pubitemid 26383078)
15. Sanai, K., Seri, K., and Inoue, S.: Inhibition of sucrose digestion and absorption by L-arabinose in rats. J. Jpn. Soc. Nutr. Food Sci., 50, 133-137, 1997.
16. Hizukuri, S.: Nutritional and physiological functions and uses of L-arabinose. J. Appl. Glycosci., 45, 159-165, 1999.
17. Inoue, S., Sanai, K., and Seri, K.: Effect of L-arabinose on blood glucose level after ingestion of sucrose-containing food in human. J. Jpn. Soc. Nutr. Food Sci., 53, 243-247, 2000.
18. Matsuo, T. and Izumori, K.: Effects of supplemental D-psicose on glucose tolerance and serum adipocytokine levels in rats fed a high-fat diet or a low-fat diet. J. Oleo. Sci., 53, 453-460, 2004.
19. Matsuo, T.: Inhibitory effects of D-psicose on glycemic responses after oral carbohydrate tolerance test in rats. J. Jpn. Soc. Nutr. Food Sci., 59, 119-121, 2006.
20. Matsuo, T. and Izumori, K.: Effects of dietary D-psicose on diurnal variation in plasma glucose and insulin concentrations of rats. Biosci. Biotechnol. Biochem., 70, 2081-2085, 2006.
21. Dahlqvist, A.: Intestinal disaccharidases. in Methods in Enzymology, vol.8, Complex Carbohydrates, eds. By Neufeld, E.F., and Ginsburg, V., Academic Press, New York, pp. 584-951, 1966.
22. Whelan, W.J.: Hydrolysis with α-amylase. in Carbohydrate Chemistry, vol.4, Starch, ed. By Whistler, R.L., Academic Press, New York, pp. 252-260, 1964.
23. + activation, inhibition by Tris (hydroxymethyl) aminomethane at the glucose subsite. Eur. J. Biocem., 41, 149-162, 1974.
24. Miura, T., Koide, T., Ohichi, R., Kako, M., Usami, M., Ishihara, E., Yasuda, N., Ishida, H., Seino, Y., and Tanigawa, K.: Effect of acarbose (α-glucosidase inhibitor) on disaccharase activity in small intestine in KK-Ay and ddY Mice. J. Nutr. Sci. Vitaminol., 44, 371-379, 1988.
25. Puls, W. and Keup, U.: Inhibition of sucrase by Tris in rats and man, demonstrated by oral loading tests with sucrose. Metabolism, 24, 93-98, 1975.
26. Cree, G.M. and Perlin, A.S.: O-Isopropylidene derivatives of D-allulose (D-psicose) and D-erythro-hexopyranose-2,3-diulose. Can. J. of Biochem., 46, 765-770, 1968.
27. Binkley, W. W.: The fate of cane juice simple sugars during molasses formation IV. Probable conversion of D-fructose to D-psicose. Int. Sugar J., 65, 105-106, 1963.
28. Miller, B.S. and Swain, T.: Chromatographic analyses of the free amino acids, organic acids and sugars in wheat plant extracts. J. Sci. Food Agric., 11, 344-348, 1960.
29. Hough, L. and Stacey, B.E.: Variation in the allitol content of Itea plants during photosynthesis. Phytochemistry, 5, 171-175, 1966.
30. Eble, T.E., Hoeksema, H., Boyack, G.A., and Savage, G.M.: Psicofuranine. I. Discovery, isolation, and properties. Antibiot. Chemother., 9, 419-420, 1959.
31. The Ministry of Health and Welfare, Japan: Information on Adverse Reactions to Drugs. no.129, Tokyo, Japan, pp. 2-3, 1994.
32. Kaiser, T. and Sawicki, P.T.: Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia, 47, 575-580, 2004. (Pubitemid 38491258)
33. Van De Laar, F.A. and Lucassen, P.L.B.J.: No evidence for a reduction of myocardial infarctions by acarbose. Eur. Heart J., 25, 1179, 2004.
34. Van De Laar, F.A., Lucassen, P.L.B.J., Akkermans, R.P., Van De Lisdonk, E.H., Rutten, G.E., and Van Weel, C.: α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care, 28, 154-163, 2005.
35. Yagi, K. and Matsuo, T.: The study on long-term toxicity of D-psicose in rats. J. Clin. Biochem. Nutr., in press.